TP53 and renal cell carcinoma: In renal cell carcinoma (RCC), Wei and colleagues identified MIER2 as a key regulator that anchors HDAC1 via p53 deacetylation and suppresses PGC1A expression, leading to lipid accumulation and promoting resistance.48